about
Surfactant protein DNA methylation: a new entrant in the field of lung cancer diagnostics? (Review)DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancersQuantitative evaluation of DNA methylation by optimization of a differential-high resolution melt analysis protocolThe immunogenicity of colorectal cancers with high-degree microsatellite instabilityImplications of mismatch repair-deficient status on management of early stage colorectal cancerUndercover: gene control by metabolites and metabolic enzymesMethylation mattersCancer: evolutionary, genetic and epigenetic aspectsPatterns of DNA methylation in the normal colon vary by anatomical location, gender, and ageInhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation.DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer.The CpG island methylator phenotype (CIMP) in colorectal cancer.DNA methylation in the rectal mucosa is associated with crypt proliferation and fecal short-chain fatty acids.Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylationAnalysis of the DNA methylation level of cancer-related genes in colorectal cancer and the surrounding normal mucosa.CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's diseaseGemcitabine functions epigenetically by inhibiting repair mediated DNA demethylation.Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis.Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study.Molecular targets of epigenetic regulation and effectors of environmental influencesDNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines.Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancerCarcinogenesis in the GI tract: from morphology to genetics and back again.Characterization of DNA hypermethylation in two cases of peritoneal mesothelioma.Alcohol, DNA methylation, and cancerGenomic and epigenomic instability, fragile sites, schizophrenia and autism.MLH1 region polymorphisms show a significant association with CpG island shore methylation in a large cohort of healthy individualsDNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver.Cancer-predicting gene expression changes in colonic mucosa of Western diet fed Mlh1+/- miceOligodendroglioma: toward molecular definitions in diagnostic neuro-oncology.Fecal molecular markers for colorectal cancer screeningBRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectumHeparanase as a molecular target of cancer chemotherapy.Gene expression profile of adult human olfactory bulb and embryonic neural stem cell suggests distinct signaling pathways and epigenetic controlCancer epigenetics takes center stage.A Molecular Clock Infers Heterogeneous Tissue Age Among Patients with Barrett's EsophagusEpigenetics and colorectal cancerMicrosatellite instability testing and its role in the management of colorectal cancer.A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation.
P2860
Q24617128-B20C0665-4F13-48A1-BC0D-484B386D70C9Q24642645-08308EAE-1407-405D-93B6-C6B239374D01Q24649854-708F6585-F9F9-4215-A483-3E427B5906A7Q24814928-73DFE3AF-B306-4A7E-B206-2565BC688506Q26772272-C43564FF-BE9F-45E2-B2FA-87D81BC4D63CQ28072281-BE73F840-2763-48DF-ADC2-34842C3128B1Q28364163-693A6C11-EAA1-4737-8983-AB75FBC7006FQ28728960-E5156B51-901F-4C89-95B5-C3BFE4C60E20Q30585819-C6B6626B-01F9-4EC3-A1F3-37D2B611E896Q33238940-8A32964E-7B81-4D58-A83B-260B530EB4B8Q33517453-94B3CD0E-C82B-45F0-BD36-474FF4F0DF6AQ33596629-6DE8AA71-4054-4645-A691-C445CDE44970Q33634174-688BA51B-792C-4344-BB0D-E68754248C4EQ33693866-8BCA83D9-5533-4669-806E-47870CAD1EFBQ33706656-D6D51036-989F-474A-8505-D3F0E6317E71Q33760744-270405E9-8616-4B7E-9A8E-09567A6A0F42Q33761140-AACEA9FE-8A24-4FA3-A4AA-A90E7E23144BQ33869648-1F960AC0-31D4-43DE-8114-D9F97D2F2917Q33988953-3EE29508-7695-4EBD-ADBA-6470D283E58EQ34025838-C97E728A-831D-4F8D-B073-DE658B58AB80Q34139601-EBDAF4DD-48FD-4E6B-B430-490135C89E55Q34153611-8302BD99-DB4F-47F5-9C5C-82192D11558BQ34194253-E7958001-0D5E-43F7-9C03-5ED69DBD1CF8Q34353359-6E622B39-974F-44E1-AFA8-9004FE6348DEQ34390179-8906DADD-03BB-4213-A0F8-1FC6DC984172Q34479635-7C586789-2C31-4E85-A3B6-BA0E8F729F99Q34512457-03E9AB53-4324-4565-82CC-512D9779D794Q34603514-5BC23606-4814-4A93-8740-C7F7070A53D5Q34681945-C5B52C1C-FE8C-4635-AACF-B0401885DBACQ35034857-39CACF32-FD24-4F59-92B8-F95D88F283D8Q35063647-F3B82C6F-94D5-4E4F-88CF-35842D83DAE6Q35579457-07320897-DBDB-44B2-948D-A2F296433816Q35596687-3BF383E4-3A77-4944-AC63-B996FD52DCBAQ35831827-8A14311B-E72D-496E-AFE6-9B22BEB8F794Q35865915-86218CC5-D16C-42EE-9029-FC99513B10E5Q35911097-7994A041-940B-4343-B501-4985BD6810F7Q36014804-331FA8AF-3687-409A-8F2A-78FC853155E8Q36081553-A4222DE0-9913-43CD-929A-E524FFB56CE6Q36124008-F79CB036-DFED-422B-8004-FC5005A7EFECQ36446183-E1E5F324-D8B7-440F-9987-6D9E139B693D
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
CpG island methylator phenotypes in aging and cancer.
@ast
CpG island methylator phenotypes in aging and cancer.
@en
type
label
CpG island methylator phenotypes in aging and cancer.
@ast
CpG island methylator phenotypes in aging and cancer.
@en
prefLabel
CpG island methylator phenotypes in aging and cancer.
@ast
CpG island methylator phenotypes in aging and cancer.
@en
P356
P1476
CpG island methylator phenotypes in aging and cancer
@en
P2093
P304
P356
10.1006/SCBI.1999.0135
P577
1999-10-01T00:00:00Z